[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.176.107. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 19, 2001

Skin Manifestations of Fabry Disease

Author Affiliations
 

Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor

JAMA. 2001;286(11):1315. doi:10.1001/jama.286.11.1311

To the Editor: Dr Schiffmann and colleagues1 reported that intravenous administration of α-galactosidase A has a number of beneficial effects in patients with Fabry disease. However, it would be of interest to know the extent of the patients' cutaneous lesions2,3 and whether they were affected by treatment with α-galactosidase A.

First Page Preview View Large
First page PDF preview
First page PDF preview
×